yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital. https://drbryanpwalsh.com/Bierley-brother-of-Kroeker-from-Adelaide?Lichstein=239 .

"we were quite surprised to find there were no significant differences," says study author.

it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done..kfi am 640 - #1 in news, talk, and sports in los angeles and orange county... a little under 60% of these encounters resulted in hospitalization and of these, about 13% required intensive care..